Literature DB >> 2858076

Tolerance to the behavioral actions of benzodiazepines.

S E File.   

Abstract

The evidence for tolerance to the behavioral effects in animals of benzodiazepines is reviewed. Tolerance develops rapidly (within 3-5 days) to the sedative effects and from 5 days of treatment to the anticonvulsant effects. In general, tolerance has not been found to anxiolytic effects after 7-15 days of treatment, although in the social interaction test it was found after 25 days. Tolerance has not been found to the locomotor stimulant effects up to 20 days of treatment. Dispositional tolerance does not occur following treatment with low doses and nor is there clear evidence of changes in benzodiazepine binding. Such changes could not account for the very different rates of tolerance to the different behavioral effects, but these could be explained if learned adaptation were to underlie tolerance or to influence the rate at which it develops. Whether the mechanism of learned adaptation is one of instrumental conditioning, classical conditioning or habituation will depend on the formal aspects of the test. It is therefore suggested that the different rates of tolerance are a function of the detailed arrangement of the experimental situation and not of the particular behavior measured or of the clinical effect the test is meant to reflect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858076     DOI: 10.1016/0149-7634(85)90037-5

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  29 in total

Review 1.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.

Authors:  V Gentil; S Tavares; C Gorenstein; C Bello; L Mathias; G Gronich; J Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.

Authors:  S E File; J Dingemanse; H L Friedman; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Facilitation of stimulatory effect of chlordiazepoxide-amphetamine combination by subacute administration of chlordiazepoxide in mice.

Authors:  M Sansone; P Renzi; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

Authors:  S E File; P S Mabbutt; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Reversal of overshadowing in a drug mixture discrimination in rats.

Authors:  J A White; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

7.  Analysis of the role of drug-predictive environmental stimuli in tolerance to the hypothermic effects of the benzodiazepine midazolam.

Authors:  J W Griffiths; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Opposite effects of agonist and inverse agonist ligands of benzodiazepine receptor on self-defensive and submissive postures in the rat.

Authors:  B Piret; A Depaulis; M Vergnes
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 9.  Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Chronic diazepam treatment in rats causes long-lasting changes in central [3H]-5-hydroxytryptamine and [14C]-gamma-aminobutyric acid release.

Authors:  P K Hitchcott; S E File; M Ekwuru; M J Neal
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.